Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,934 | 252 | 98.1% |
| Education | $96.00 | 1 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,425 | 82 | $0 (2024) |
| Janssen Biotech, Inc. | $459.33 | 18 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $434.64 | 29 | $0 (2024) |
| Celgene Corporation | $316.60 | 21 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $294.05 | 13 | $0 (2024) |
| Ardelyx, Inc. | $233.71 | 13 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $220.39 | 5 | $0 (2024) |
| Gilead Sciences, Inc. | $204.39 | 11 | $0 (2024) |
| GENZYME CORPORATION | $198.16 | 6 | $0 (2024) |
| Evoke Pharma, Inc. | $165.40 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,430 | 69 | ABBVIE INC. ($373.90) |
| 2023 | $1,975 | 91 | ABBVIE INC. ($557.96) |
| 2022 | $1,205 | 64 | ABBVIE INC. ($340.20) |
| 2021 | $420.63 | 29 | AbbVie Inc. ($153.36) |
All Payment Transactions
253 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: Gastroenterology | ||||||
| 12/16/2024 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $19.74 | General |
| 12/13/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | CREON (Drug), LINZESS, VIBERZI | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/06/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/06/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.02 | General |
| 11/04/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Hematology | ||||||
| 11/01/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $27.12 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Immunology | ||||||
| 10/23/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $10.02 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $36.02 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $32.37 | General |
| Category: VIROLOGY | ||||||
| 10/18/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/04/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Immunology | ||||||
| 10/03/2024 | ABBVIE INC. | CREON (Drug), LINZESS, VIBERZI | Food and Beverage | In-kind items and services | $8.48 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/03/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $2.85 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/02/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: LIVER DISEASE | ||||||
| 09/30/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $28.02 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: Gastroenterology | ||||||
| 09/13/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.72 | General |
| Category: IMMUNOLOGY | ||||||
| 09/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 211 | 262 | $72,983 | $22,135 |
| 2022 | 4 | 200 | 224 | $57,653 | $17,421 |
| 2021 | 7 | 169 | 195 | $47,720 | $15,589 |
| 2020 | 10 | 385 | 427 | $85,580 | $29,716 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 81 | 132 | $33,792 | $10,056 | 29.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 76 | 76 | $25,688 | $7,916 | 30.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $5,364 | $1,795 | 33.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 31 | $5,642 | $1,530 | 27.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $2,497 | $838.75 | 33.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 65 | 65 | $21,973 | $6,283 | 28.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 56 | 71 | $18,180 | $5,731 | 31.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 46 | 55 | $10,012 | $3,315 | 33.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 33 | 33 | $7,488 | $2,091 | 27.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 43 | 56 | $12,653 | $4,512 | 35.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 41 | 41 | $13,593 | $4,396 | 32.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 21 | 34 | $6,800 | $2,168 | 31.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 28 | $4,470 | $1,542 | 34.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 11 | 11 | $4,290 | $1,331 | 31.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 13 | 13 | $2,734 | $925.78 | 33.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 12 | 12 | $3,180 | $713.33 | 22.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 76 | 88 | $18,040 | $6,591 | 36.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 39 | 39 | $12,285 | $4,472 | 36.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 78 | 84 | $11,760 | $4,390 | 37.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 54 | 54 | $11,070 | $4,024 | 36.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 31 | 33 | $8,745 | $2,688 | 30.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 25 | 38 | $7,600 | $2,613 | 34.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 18 | 18 | $7,020 | $2,191 | 31.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 34 | 43 | $6,200 | $2,086 | 33.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 14 | 14 | $1,820 | $363.76 | 20.0% |
About Shaina Samec, PA-C
Shaina Samec, PA-C is a Medical healthcare provider based in Lancaster, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/25/2018. The National Provider Identifier (NPI) number assigned to this provider is 1780169821.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Shaina Samec, PA-C has received a total of $5,030 in payments from pharmaceutical and medical device companies, with $1,430 received in 2024. These payments were reported across 253 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($4,934).
As a Medicare-enrolled provider, Samec has provided services to 965 Medicare beneficiaries, totaling 1,108 services with total Medicare billing of $84,860. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Medical
- Location Lancaster, PA
- Active Since 09/25/2018
- Last Updated 04/07/2025
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1780169821
Products in Payments
- ZEPOSIA (Drug) $431.35
- DUPIXENT (Biological) $418.55
- MAVYRET (Drug) $416.87
- XIFAXAN (Drug) $367.48
- STELARA (Biological) $361.07
- LINZESS (Drug) $271.80
- ENTYVIO (Biological) $239.03
- IBSRELA (Drug) $233.71
- CREON (Drug) $206.67
- RINVOQ (Biological) $205.99
- GIMOTI (Drug) $165.40
- VIBERZI (Drug) $151.08
- Linzess (Drug) $148.66
- TREMFYA (Drug) $98.26
- SKYRIZI (Biological) $97.12
- XELJANZ (Drug) $87.31
- TRULANCE (Drug) $67.16
- Talicia (Drug) $56.30
- SUTAB (Drug) $55.34
- INJECTAFER (Drug) $53.54
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Lancaster
Mr. David Doriguzzi, Pa-C, PA-C
Medical — Payments: $113,979
Mrs. Kelly O'sullivan, Pa-C, PA-C
Medical — Payments: $6,769
Mr. Carlos Guerrero, Fnp, FNP
Medical — Payments: $6,199
Mrs. Lori Rodriguez, Pa, PA
Medical — Payments: $3,253
Tina Young, Pa-C, PA-C
Medical — Payments: $2,908
Jamie Weaver, P.a.-C, P.A.-C
Medical — Payments: $2,895